RE:RE:IRENE StudyThe IRENE study was in late-stage metastatic breast cancer patients who had previously received 1-2 lines of chemotherapy. ONCY has prudently decided to move towards the earlier treatment of breast cancer on the expected relapse of ADCs, like Enhertu, in their treatment of breast cancer.